Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 USD | +0.23% | +1.69% | +59.51% |
May. 10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
May. 09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 92
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Russell
FOU | Founder | 54 | 16-12-31 |
Kevin Koch
CEO | Chief Executive Officer | 63 | 16-12-31 |
R. Carruthers
DFI | Director of Finance/CFO | 66 | 20-10-15 |
Joanne Donovan
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-04-26 |
Corporate Officer/Principal | 44 | 20-08-31 | |
Marc Semigran
PRN | Corporate Officer/Principal | 67 | 22-12-19 |
John Moore
LAW | General Counsel | 59 | 20-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Root
BRD | Director/Board Member | 64 | 19-07-31 |
Kevin Koch
CEO | Chief Executive Officer | 63 | 16-12-31 |
Peter Thompson
FOU | Founder | 64 | 16-12-31 |
Laura Brege
BRD | Director/Board Member | 66 | 20-11-30 |
Jonathan Fox
BRD | Director/Board Member | 66 | 23-03-01 |
Badreddin Edris
FOU | Founder | 37 | 16-12-31 |
Alan Russell
FOU | Founder | 54 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 93,284,528 | 92,970,355 ( 99.66 %) | 0 | 99.66 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.51% | 1.63B | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- EWTX Stock
- Company Edgewise Therapeutics, Inc.